Presenting characteristics and prevalence of polypoidal choroidal vasculopathy in Scandinavian patients with treatment-naïve exudative age-related macular degeneration
- PMID: 29193780
- DOI: 10.1111/aos.13646
Presenting characteristics and prevalence of polypoidal choroidal vasculopathy in Scandinavian patients with treatment-naïve exudative age-related macular degeneration
Abstract
Purpose: To study presenting characteristics and prevalence of polypoidal choroidal vasculopathy (PCV) in Scandinavian Caucasians with treatment-naïve exudative age-related macular degeneration (AMD).
Methods: We reviewed all patients referred in year 2014 and diagnosed using fundus examination, optical coherence tomography, and fluorescein and indocyanine green angiography (ICGA). Details of found PCVs and its subtypes (clinical and angiographical) were correlated to the baseline best-corrected visual acuity (BCVA).
Results: Of 299 Caucasian patients with a tentative diagnosis of exudative AMD, 18 eyes of 17 patients (5.7%, CI 95%: 3.5-9.1%) had PCV. Patients with PCV were 75.8 (SD: 7.5) years old and 11 (65%) were females. Lesions were predominantly extramacular. Most eyes (56%) had subretinal haemorrhage, 39% had the exudative type and one (6%) eye had the quiescent type. Larger lesion area and disruption of the foveal inner-segment/outer-segment layer correlated with worse baseline BCVA. Polypoidal choroidal vasculopathy (PCV) type 1 was present in 50% and PCV type 2 in the other 50%. Polypoidal choroidal vasculopathy (PCV) type 1 was associated with a worse baseline BCVA and greater lesion size.
Conclusion: Polypoidal choroidal vasculopathy (PCV) is not a rare condition in Danes with exudative AMD and presents often extramacular and with haemorrhage. This study underscores the importance of ICGA as a part of the diagnostic repertoire in AMD and suggests its routine use in Scandinavian populations.
Keywords: Caucasians; Scandinavians; clinical presentation; polypoidal choroidal vasculopathy.
© 2017 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.
Similar articles
-
PREVALENCE OF POLYPOIDAL CHOROIDAL VASCULOPATHY IN WHITE PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Systematic Review and Meta-Analysis.Retina. 2018 Dec;38(12):2363-2371. doi: 10.1097/IAE.0000000000001872. Retina. 2018. PMID: 29059101
-
DETAILED CHARACTERIZATION OF CHOROIDAL MORPHOLOGIC AND VASCULAR FEATURES IN AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.Retina. 2017 Dec;37(12):2269-2280. doi: 10.1097/IAE.0000000000001481. Retina. 2017. PMID: 28145972
-
Comparison of subfoveal choroidal structures in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.Jpn J Ophthalmol. 2018 Sep;62(5):576-583. doi: 10.1007/s10384-018-0615-4. Epub 2018 Aug 1. Jpn J Ophthalmol. 2018. PMID: 30069649
-
Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy.Graefes Arch Clin Exp Ophthalmol. 2018 Dec;256(12):2309-2317. doi: 10.1007/s00417-018-4143-1. Epub 2018 Sep 27. Graefes Arch Clin Exp Ophthalmol. 2018. PMID: 30259090 Review.
-
Differentiating Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy Using OCT B-Scan.Ophthalmol Retina. 2021 Oct;5(10):954-961. doi: 10.1016/j.oret.2021.05.009. Epub 2021 May 19. Ophthalmol Retina. 2021. PMID: 34022443
Cited by
-
The Use of Vascular Endothelial Growth Factor Inhibitors and Complementary Treatment Options in Polypoidal Choroidal Vasculopathy: A Subtype of Neovascular Age-Related Macular Degeneration.Int J Mol Sci. 2018 Sep 3;19(9):2611. doi: 10.3390/ijms19092611. Int J Mol Sci. 2018. PMID: 30177632 Free PMC article. Review.
-
European Prevalence of Polypoidal Choroidal Vasculopathy: A Systematic Review, Meta-Analysis, and Forecasting Study.J Clin Med. 2022 Aug 16;11(16):4766. doi: 10.3390/jcm11164766. J Clin Med. 2022. PMID: 36013005 Free PMC article. Review.
-
The transcriptome of peripheral blood mononuclear cells in patients with clinical subtypes of late age-related macular degeneration.Immun Ageing. 2019 Aug 15;16:20. doi: 10.1186/s12979-019-0160-0. eCollection 2019. Immun Ageing. 2019. PMID: 31428180 Free PMC article.
-
Plasma Levels of Matrix Metalloprotease MMP-9 and Tissue Inhibitor TIMP-1 in Caucasian Patients with Polypoidal Choroidal Vasculopathy.Vision (Basel). 2020 May 15;4(2):27. doi: 10.3390/vision4020027. Vision (Basel). 2020. PMID: 32429088 Free PMC article.
-
Polypoidal choroidal vasculopathy-characteristics and response to treatment with bevacizumab in caucasian patients.Int J Retina Vitreous. 2022 Nov 22;8(1):82. doi: 10.1186/s40942-022-00432-x. Int J Retina Vitreous. 2022. PMID: 36414995 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources